{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:43:16Z","timestamp":1784191396053,"version":"3.55.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/mph.0000000000000343","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T20:17:36Z","timestamp":1430511456000},"page":"e285-e291","source":"Crossref","is-referenced-by-count":4,"title":["Safety and Effectiveness of Micafungin in Japanese Pediatric Patients"],"prefix":"10.1097","volume":"37","author":[{"given":"Chie","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hanadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshiyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210209","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.11.91","article-title":"Micafungin use in children.","volume":"9","author":"Emiroglu","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R2-19-20210209","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1469-0691.2010.03288.x","article-title":"Epidemiology of invasive fungal infections in neonates and children.","volume":"16","author":"Steinbach","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R3-19-20210209","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/INF.0b013e3182127eaf","article-title":"Safety of micafungin in pediatric clinical trials.","volume":"30","author":"Arrieta","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R4-19-20210209","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.2006-2931","article-title":"Antifungal therapy in children with invasive fungal infections: a systematic review.","volume":"119","author":"Blyth","year":"2007","journal-title":"Pediatrics"},{"key":"R5-19-20210209","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/501020","article-title":"Micafungin: a new echinocandin.","volume":"42","author":"Chandrasekar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R6-19-20210209","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2174\/092986707780597970","article-title":". Role of micafungin in the antifungal armamentarium.","volume":"14","author":"Ikeda","year":"2007","journal-title":"Curr Med Chem"},{"key":"R8-19-20210209","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1517\/14740338.2011.557062","article-title":". Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.","volume":"10","author":"Cornely","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"R9-19-20210209","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10156-011-0219-0","article-title":". Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report.","volume":"17","author":"Hanadate","year":"2011","journal-title":"J Infect Chemother"},{"key":"R10-19-20210209","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00365540410020406","article-title":". A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan.","volume":"36","author":"Kohno","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"R11-19-20210209","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":". Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"R12-19-20210209","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/clpt.2009.200","article-title":". Safety and pharmacokinetics of repeat-dose micafungin in young infants.","volume":"87","author":"Benjamin","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R13-19-20210209","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/01.inf.0000245103.07614.e1","article-title":". The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.","volume":"25","author":"Heresi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R14-19-20210209","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":". Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.","volume":"27","author":"Queiroz-Telles","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R15-19-20210209","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/INF.0b013e3181910e2d","article-title":". Pharmacokinetics of an elevated dosage of micafungin in premature neonates.","volume":"28","author":"Smith","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R16-19-20210209","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1080\/10428190500272499","article-title":". Breakthrough trichosporonosis in patients with acute myeloid leukemia receiving micafungin.","volume":"47","author":"Akagi","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R17-19-20210209","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/500323","article-title":". Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.","volume":"42","author":"Matsue","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000000343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:46:44Z","timestamp":1620964004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201507000-00019"}},"subtitle":["Results of a Postmarketing Surveillance Study"],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000343","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}